Compound Detail
CHEMBL488436
AZD-5438 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL488436 |
| Name | AZD-5438 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | WJRRGYBTGDJBFX-UHFFFAOYSA-N |
39
Targets
59
Activities
3
Assay Types
6
PK Parameters
20
Publications
2
Known Names
1
Indications
1
Mechanisms
Molecular Properties
371.5
MW (Da)
3.38
ALogP
7
HBA
1
HBD
89.8
PSA (Ų)
0.74
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cyclin-dependent kinase inhibitor | INHIBITOR | Cyclin-dependent kinase | ✓ | ✓ |
Indications
Neoplasms
Activity Summary
IC50 38 meas. best 8.22
Kd 19 meas. best 7.26
EC50 2 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Spiral organ of cochlea CHEMBL4296537 | EC50 | 8.3 | 8.3 | 5.0 | 1 |
| G1/S-specific cyclin-E1 CHEMBL3617 | IC50 | 8.22 | 8.22 | 6.0 | 1 |
| Cyclin-dependent kinase 2 CHEMBL301 | IC50 | 8.22 | 8.22 | 6.0 | 5 |
| Cyclin-dependent kinase 1 CHEMBL308 | IC50 | 7.88 | 7.6725 | 13.3 | 4 |
| G2/mitotic-specific cyclin-B1 CHEMBL2412 | IC50 | 7.8 | 7.8 | 16.0 | 1 |
| Cyclin-dependent kinase 9 CHEMBL3116 | IC50 | 7.74 | 7.72 | 18.2 | 2 |
| CDK9/cyclin T1 CHEMBL2111389 | IC50 | 7.7 | 7.7 | 20.0 | 1 |
| Cyclin-T1 CHEMBL2108 | IC50 | 7.7 | 7.7 | 20.0 | 1 |
| G1/S-specific cyclin-D3 CHEMBL2422 | IC50 | 7.68 | 7.68 | 21.0 | 1 |
| Cyclin-dependent kinase 6 CHEMBL2508 | IC50 | 7.66 | 7.66 | 22.1 | 1 |
| CDK2/Cyclin A2 CHEMBL3038469 | IC50 | 7.35 | 7.35 | 45.0 | 1 |
| Cyclin-A2 CHEMBL2582 | IC50 | 7.35 | 7.35 | 45.0 | 1 |
| Glycogen synthase kinase-3 alpha CHEMBL2850 | Kd | 7.26 | 7.26 | 55.0 | 1 |
| Glycogen synthase kinase-3 beta CHEMBL262 | Kd | 7.21 | 7.21 | 62.0 | 1 |
| Trypanosoma brucei brucei CHEMBL612851 | IC50 | 7.08 | 6.8367 | 84.0 | 3 |
| Trypanosoma brucei CHEMBL612849 | IC50 | 6.68 | 6.63 | 210.0 | 2 |
| AP2-associated protein kinase 1 CHEMBL3830 | Kd | 6.64 | 6.64 | 228.0 | 1 |
| Cyclin-dependent kinase 9 CHEMBL3116 | Kd | 6.5 | 6.5 | 320.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 6.44 | 6.44 | 360.0 | 1 |
| Cyclin-dependent kinase 4 CHEMBL331 | IC50 | 6.35 | 6.35 | 450.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 6.33 | 6.33 | 470.0 | 1 |
| LoVo CHEMBL614721 | IC50 | 6.2 | 6.1333 | 630.0 | 3 |
| Cyclin-dependent kinase 5 CHEMBL4036 | Kd | 6.2 | 6.2 | 627.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 6.16 | 6.16 | 700.0 | 1 |
| HeLa CHEMBL399 | IC50 | 6.14 | 6.03 | 730.0 | 2 |
| Cyclin-dependent kinase 2 CHEMBL301 | Kd | 6.14 | 6.14 | 721.0 | 1 |
| Interleukin-1 receptor-associated kinase 3 CHEMBL5081 | Kd | 6.11 | 6.11 | 771.0 | 1 |
| BMP-2-inducible protein kinase CHEMBL4522 | Kd | 6.08 | 6.08 | 826.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 5.97 | 5.97 | 1080.0 | 1 |
| Leishmania infantum CHEMBL612848 | IC50 | 5.94 | 5.94 | 1150.0 | 1 |
| Casein kinase I isoform delta CHEMBL2828 | Kd | 5.93 | 5.93 | 1169.0 | 1 |
| Unchecked CHEMBL612545 | Kd | 5.82 | 5.82 | 1527.0 | 1 |
| Mitogen-activated protein kinase 8 CHEMBL2276 | Kd | 5.78 | 5.78 | 1676.0 | 1 |
| Mitogen-activated protein kinase 9 CHEMBL4179 | Kd | 5.72 | 5.72 | 1898.0 | 1 |
| Casein kinase II subunit alpha' CHEMBL4070 | Kd | 5.72 | 5.72 | 1882.0 | 1 |
| Cyclin-dependent kinase 1 CHEMBL308 | Kd | 5.7 | 5.7 | 1992.0 | 1 |
| Serine/threonine-protein kinase D2 CHEMBL4900 | Kd | 5.64 | 5.64 | 2314.0 | 1 |
| Cyclin-dependent kinase 7 CHEMBL3055 | Kd | 5.63 | 5.63 | 2332.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.5 | 5.5 | 3200.0 | 1 |
| Leishmania major CHEMBL612879 | IC50 | 5.5 | 5.5 | 3150.0 | 1 |
| Casein kinase I isoform alpha CHEMBL2793 | Kd | 5.49 | 5.49 | 3238.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 5.14 | 5.14 | 7200.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.97 | 4.97 | 10670.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 6946.49 | ng.hr.mL-1 | Mus musculus |
| CL | 21.8 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 6400.0 | nM | Mus musculus |
| F | 91.0 | % | Mus musculus |
| Fu | 0.087 | - | Rattus norvegicus |
| Tmax | 0.33 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine